SHANGHAI, Dec. 8, 2014 /PRNewswire/ -- The Medela family company has been a leader in the development and production of breastfeeding products for more than 50 years. Medela also invests heavily in fundamental research and presents results of this research every year in its Breastfeeding and Lactation Symposium. The conference in 2015 will take place from April 17-18 in Warsaw, Poland, and marks the 10th anniversary of this Symposium series which is traditionally open to all interested healthcare professionals.
"A central theme for this Symposium series is that it brings to its audience the latest, current high-level research. As such, it serves as a guide for the hot topics and current research trends," says Leon Mitoulas, Head of Medela Breastfeeding Research. In addition, the yearly symposium acts as an important platform bridging research and practice through its thought provoking and inspiring agenda based around three major themes: Latest recommendations for research based practice; the unique components of human milk and the value of human milk in the NICU.
Program：
Friday, April 17, 2015
| The unique components of human milk |
| Assoc/Prof Donna Geddes (AU) Appetite regulation of breastfed infants: milk composition, appetite control factors and gastric emptying |
| Ms Anna Cannon (PhD Candidate) (AU/PL) The effect of breastmilk leptin on breastfeeding behaviour and gastric emptying |
| Dr Foteini Hassiotou (AU) Breastmilk imparts the mother's stem cells to the infant: boosting early infant development? |
Saturday, April 18, 2015
| Latest recommendations for research based practice |
| Dr Maria Wilinska (PL) Effect of implementation programme of exclusive human milk feeding to neonatal intensive care unit |
| Prof Cindy-Lee Dennis (CA) Promoting exclusive breastfeeding: current evidence-based practices and future ideas |
| Prof Matthias Keller (DE) NeoPAss®, a multiprofessional clinical care pathway programme for family integrated care |
| Value of human milk in NICU |
| Prof Christoph Fusch (CA/DE) Postnatal growth restriction and individualised fortification |
| Prof Diane Spatz (US) Ensuring Human Milk in the NICU |
| Prof Shoo Lee (CA) Human milk and prevention of NEC in the NICU |
More information under www.medela-symposium.com.
Contact
Martin Elbel, Medela AG, Head of Corporate Communications
martin.elbel@medela.ch, Phone +41 41 769 54 37 (Office), +41 79 881 78 28 (Mobile)
About Medela:
Founded in 1961 by Olle Larsson and headquartered in the Canton of Zug, Switzerland, Medela is part of the group Olle Larsson Holding AG and continues to grow under the leadership of the second generation of the Larsson family. Medela concentrates on two divisions: "Breastfeeding", leading in the development and production of breastfeeding products, and "Healthcare", engineering and manufacturing highly innovative medical vacuum technology solutions. Medela conducts fundamental research together with leading scientists, medical professionals and universities, and uses the research results in the development of its products. Medela has 18 subsidiaries in Europe, North America and Asia, and together with independent partners distributes its products in more than 90 countries. The company employs around 1,500 staff worldwide, 330 of whom are located in the Canton of Zug. www.medela.com
